Titan Pharmaceuticals Inc (OTCBB - OTCQB:TTNP)

Data as of Jan 28
 -0.014 / -2.78%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

Titan Pharmaceuticals, Inc. is a biopharmaceutical company, which is developing proprietary therapeutics primarily for the treatment of serious medical disorders. Its products include Probuphine, ProNeura and Fanapt. The company was founded by Louis R. Bucalo in February 1992 and is headquartered in South San Francisco, CA.

Contact Information

Titan Pharmaceuticals, Inc.
400 Oyster Point Boulevard
South San Francisco California 94080-1921
P:(650) 244-4990
Investor Relations:



Other institutional6.23%
Individual stakeholders12.38%
Mutual fund holders0.00%

Top Executives

Sunil BhonslePresident, Secretary & Director
Brian CrowleyVice President-Finance
Katherine L. Glassman-BeebeChief Development Officer & Executive VP

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.